Vanguard Group’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$41.8K Hold
407
– – ﹤0.01% 4262
2025
Q3
$115K Buy
407
+215
+112% +$90.2K ﹤0.01% 4209
2025
Q2
$100K Hold
192
– – ﹤0.01% 4149
2025
Q1
$122K Buy
192
+107
+126% +$113K ﹤0.01% 4116
2024
Q4
$126K Buy
85
+53
+166% +$73.6K ﹤0.01% 4151
2024
Q3
$46.4K Hold
32
– – ﹤0.01% 4249
2024
Q2
$61.3K Hold
32
– – ﹤0.01% 4275
2024
Q1
$38.5K Sell
32
-49
-60% -$92.8K ﹤0.01% 4338
2023
Q4
$263K Hold
81
– – ﹤0.01% 4180
2023
Q3
$374K Hold
81
– – ﹤0.01% 4137
2023
Q2
$402K Hold
81
– – ﹤0.01% 4178
2023
Q1
$486K Hold
81
– – ﹤0.01% 4131
2022
Q4
$461K Buy
81
+20
+33% +$146K ﹤0.01% 4119
2022
Q3
$600K Buy
61
+32
+110% +$443K ﹤0.01% 4164
2022
Q2
$215K Hold
29
– – ﹤0.01% 4460
2022
Q1
$298K Hold
29
– – ﹤0.01% 4472
2021
Q4
$937K Hold
29
– – ﹤0.01% 4285
2021
Q3
$1.12M Hold
29
– – ﹤0.01% 4224
2021
Q2
$1.28M Buy
29
+23
+383% +$1.07M ﹤0.01% 4101
2021
Q1
$221K Buy
6
+4
+200% +$187K ﹤0.01% 4244
2020
Q4
$75K Buy
+2
New +$55.8K ﹤0.01% 4162

Other funds holding GOVX

Vanguard Group's GOVX Position: Q4 2025 in Review

Vanguard Group held its GeoVax Labs (GOVX) position steady in Q4 2025 at 407 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4262.

Vanguard Group first reported a position in GOVX in Q4 2020 and has held it in 21 quarters since. The position peaked at $1.28M in Q2 2021. 16 funds tracked by Wall St. Rank hold GOVX as of Q4 2025.

  • Vanguard Group held 407 shares of GeoVax Labs worth $41.8K as of Q4 2025.
  • Vanguard Group left its GeoVax Labs share count unchanged in Q4 2025.
  • GeoVax Labs made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4262 holding.
  • Vanguard Group first reported a position in GeoVax Labs in Q4 2020 and has held it in 21 quarters since.
  • Vanguard Group's GeoVax Labs position peaked at $1.28M in Q2 2021.
  • 16 funds tracked by Wall St. Rank held GeoVax Labs as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.